Home Articoli
Linee guida per modificare le definizioni di malattia: una checklist

Guidelines & Standards

Linee guida per modificare le definizioni di malattia: una checklist
Jenny Doust, Per O. Vandvik, Amir Qaseem, Reem A. Mustafa, Andrea R. Horvath, Allen Frances, Lubna Al-Ansary, Patrick Bossuyt, Robyn L. Ward, Ina Kopp, Laragh Gollogly, Holger Schunemann, Paul Glasziou, per il Guidelines International Network (G-I-N) Preventing Overdiagnosis Working Group

Evidence 2018;10(9): e1000187 doi: 10.4470/E1000187

Pubblicato: 15 ottobre 2018

Copyright: © 2017 American Medical Association -

Affiliazione degli Autori

Jenny Doust, Centre for Research in Evidence Based Practice, Bond University, Gold Coast, Australia
Per O. Vandvik, Department of Medicine, Innlandet Hospital Trust, Gjøvik, Norway
Amir Qaseem, Department of Clinical Policy, American College of Physicians, Philadelphia, Pennsylvania
Reem A. Mustafa, Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada, Department of Medicine, McMaster University, Hamilton, Canada
Andrea R. Horvath, NSW Health Pathology SEALS Department of Clinical Chemistry and Endocrinology, Prince of Wales Hospital, Sydney, Australia
Allen Frances, Duke University, Durham, North Carolina
Lubna Al-Ansary, Department of Family and Community Medicine, King Saud University, Riyadh, Saudi Arabia
Patrick Bossuyt, Department of Clinical Epidemiology and Biostatistics, University of Amsterdam, Amsterdam, the Netherlands
Robyn L. Ward, Brian Wilson Chancellery, University of Queensland, St Lucia, Australia
Ina Kopp, Association of the Scientific Medical Societies’ Institute of Medical Knowledge-Management (AWMF-IMWi), Philipps-University, Marburg, Germany
Laragh Gollogly, Department of Strategy, Policy, and Information, World Health Organisation, Geneva, Switzerland
Holger Schunemann, Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada
Paul Glasziou, Centre for Research in Evidence Based Practice, Bond University, Gold Coast, Australia
per il Guidelines International Network (G-I-N) Preventing Overdiagnosis Working Group,

Contributo degli Autori

CONTRIBUTO DEGLI AUTORI
Doust e Glasziou hanno avuto pieno accesso a tutti i dati dello studio e sono responsabili dell’integrità dei dati e dell’accuratezza delle analisi dei dati.
Ideazione e disegno dello studio: Doust, Vandvik, Qaseem, Mustafa, Horvath, Frances, Al-Ansary, Bossuyt, Ward, Kopp, Gollogly, Schunemann, Glasziou.
Raccolta, analisi o interpretazione dei dati: tutti gli autori.
Stesura del draft del manoscritto: tutti gli autori.
Revisione critica del manoscritto per contenuti intellettuali rilevanti: tutti gli autori.
Fundraising: Glasziou.
Supporto amministrativo, tecnico e logistico: Doust, Vandvik, Glasziou.

Disclosure dei conflitti di interesse

Nessuno dichiarato

Indirizzo per la corrispondenza

jdoust@bond.edu.au